PlainRecalls
FDA Drug Moderate Class II Terminated

Levothyroxine Sodium Tablets, USP, 200 mcg, 100-count bottle, Rx only, Distributed by Mylan Pharmaceuticals Inc. Morgantown, WV 26505, NDC 0378-1819-01

Reported: February 19, 2014 Initiated: January 14, 2014 #D-1084-2014

Product Description

Levothyroxine Sodium Tablets, USP, 200 mcg, 100-count bottle, Rx only, Distributed by Mylan Pharmaceuticals Inc. Morgantown, WV 26505, NDC 0378-1819-01

Reason for Recall

Subpotent Drug: Assay results obtained during stability testing for Levothyroxine Sodium Tablets, USP were below specification.

Details

Units Affected
138,970 bottles
Distribution
Nationwide.
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Levothyroxine Sodium Tablets, USP, 200 mcg, 100-count bottle, Rx only, Distributed by Mylan Pharmaceuticals Inc. Morgantown, WV 26505, NDC 0378-1819-01. Recalled by Mylan Pharmaceuticals Inc.. Units affected: 138,970 bottles.
Why was this product recalled?
Subpotent Drug: Assay results obtained during stability testing for Levothyroxine Sodium Tablets, USP were below specification.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 19, 2014. Severity: Moderate. Recall number: D-1084-2014.